Clinical Trial Update: Rescue FMT with Bezlotoxumab for Recurrent C. Difficile Infection

View source ↗

Summary

A completed trial examined using bezlotoxumab alongside fecal microbiota transplantation for recurrent Clostridioides difficile infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridioides Difficile Infection

Drugs mentioned

• Zinplava (bezlotoxumab)

Snippet

Sponsor: Alexander Khoruts | Conditions: Recurrent C. Difficile Infection | Status: COMPLETED